THYROID STIMULATING HORMONE (TSH) - ANVISA Registration 10345161732

Access comprehensive regulatory information for THYROID STIMULATING HORMONE (TSH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345161732 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., VEDALAB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345161732
Registration Details
ANVISA Registration Number: 10345161732
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ADVIA CENTAUR TSH3-Ultra (TSH3-UL)
Risk Class II

Registration Details

10345161732

25351040858201050

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Apr 26, 2010

VIGENTE

09/18/2025 19:00:01